Prelude Therapeutics Incorporated (PRLD)
NASDAQ·Healthcare·Biotechnology
$4.20
-13.40%
Mkt Cap $261.32M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (6 analysts)
$8.00
Range $8.00 – $8.00
Implied Upside
+90.5%
Consensus $8.00 vs current $4.20
NASDAQ·Healthcare·Biotechnology
$4.20
-13.40%
Mkt Cap $261.32M
Buy
2
Hold
0
Sell
0
Price Target (6 analysts)
$8.00
Range $8.00 – $8.00
+90.5%
Consensus $8.00 vs current $4.20